S-GLYN Trademark

Trademark Overview


On Friday, May 10, 2024, a trademark application was filed for S-GLYN with the United States Patent and Trademark Office. The USPTO has given the S-GLYN trademark a serial number of 79404587. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Sunday, November 24, 2024. This trademark is owned by Samsung Biologics Co., Ltd.. The S-GLYN trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylation drugs; processing of chemicals.

High-efficiency scientific laboratory service for glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; molecular analysis; development of biotechnology; biotechnological research; biological analysis; biological research; research of biologics; biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; genetic research; computer programming in the medical field; medical laboratori...

General Information


Serial Number79404587
Word MarkS-GLYN
Filing DateFriday, May 10, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateSunday, November 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylation drugs; processing of chemicals.
Goods and ServicesHigh-efficiency scientific laboratory service for glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; molecular analysis; development of biotechnology; biotechnological research; biological analysis; biological research; research of biologics; biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; genetic research; computer programming in the medical field; medical laboratories; computer project management services relating to imaging medical data; medicine research; analysis and evaluation of medical product development; providing information on the testing, inspection and research of medical products; evaluating of clinical trial progress; clinical trials.

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Biologics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, September 19, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, September 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2024APPLICATION FILING RECEIPT MAILED
Sunday, November 24, 2024ASSIGNED TO EXAMINER